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ABSTRACT
While SecA is the ATPase component of the major bacterial secretory (Sec) system, mycobacteria and some Gram-positive
pathogens have a second paralog, SecA2. In bacteria with two SecA paralogs, each SecA is functionally distinct, and they cannot
compensate for one another. Compared to SecA1, SecA2 exports a distinct and smaller set of substrates, some of which have roles
in virulence. In the mycobacterial system, some SecA2-dependent substrates lack a signal peptide, while others contain a signal
peptide but possess features in the mature protein that necessitate a role for SecA2 in their export. It is unclear how SecA2 func-
tions in protein export, and one open question is whether SecA2 works with the canonical SecYEG channel to export proteins. In
this study, we report the structure ofMycobacterium tuberculosis SecA2 (MtbSecA2), which is the first structure of any SecA2
protein. A high level of structural similarity is observed between SecA2 and SecA1. The major structural difference is the absence
of the helical wing domain, which is likely to play a role in howMtbSecA2 recognizes its unique substrates. Importantly, struc-
tural features critical to the interaction between SecA1 and SecYEG are preserved in SecA2. Furthermore, suppressor mutations
of a dominant-negative secA2mutant map to the surface of SecA2 and help identify functional regions of SecA2 that may pro-
mote interactions with SecYEG or the translocating polypeptide substrate. These results support a model in which the mycobac-
terial SecA2 works with SecYEG.
IMPORTANCE
SecA2 is a paralog of SecA1, which is the ATPase of the canonical bacterial Sec secretion system. SecA2 has a nonredundant func-
tion with SecA1, and SecA2 exports a distinct and smaller set of substrates than SecA1. This work reports the crystal structure of
SecA2 ofMycobacterium tuberculosis (the first SecA2 structure reported for any organism). Many of the structural features of
SecA1 are conserved in the SecA2 structure, including putative contacts with the SecYEG channel. Several structural differences
are also identified that could relate to the unique function and selectivity of SecA2. Suppressor mutations of a secA2mutant map
to the surface of SecA2 and help identify functional regions of SecA2 that may promote interactions with SecYEG.
SecA is the ATPase component of the bacterial Sec secretionpathway (1). SecA recognizes proteins destined for export
from the cytoplasm and provides energy to translocate them
across the cytoplasmic membrane by way of the SecYEG translo-
case channel. The proteins exported by SecA are synthesized as
preproteins with N-terminal signal peptides. Following transloca-
tion, the signal peptide is cleaved to release the mature protein
species. Both the signal peptide and features of the mature protein
are recognized by SecA (2). Some Gram-positive and acid-fast
bacteria, including mycobacteria, have a SecA paralog referred to
as SecA2. SecA1, the canonical SecA in these organisms, is essen-
tial for growth and responsible for the majority of protein export
that occurs. In contrast, SecA2 is typically not essential and is
required for the export of a more limited subset of proteins (3, 4).
Studies in mycobacteria show that even when overexpressed, the
two SecA proteins are unable to compensate for each other (5).
Thus, each SecA protein has distinct functions in protein export.
In Mycobacterium tuberculosis, SecA2 (MtbSecA2) is not essential
for growth in culture, but it is essential for virulence in vivo (6, 7).
Furthermore, SecA2 is required for intracellular growth of M. tu-
berculosis in macrophages (8). The role of SecA2 in promoting
growth in macrophages is attributed to a role in preventing phago-
some maturation (9). In Mycobacterium marinum, export of pro-
tein kinase G (PknG) by the SecA2 pathway is suggested to at least
be partially responsible for the SecA2 effect on phagosome matu-
ration (10). In M. tuberculosis, the SecA2 pathway is additionally
required to restrict apoptosis of infected macrophages. A possible
explanation for the latter effect is the SecA2-dependent secretion
of superoxide dismutase, which may reduce reactive oxygen spe-
cies (ROS)-mediated apoptosis (11, 12). An association between
SecA2 and the secretion of virulence factors extends to other bac-
terial pathogens as well (13–16). There is also an intriguing asso-
ciation between the SecA2 pathway and the export of S-layer pro-
teins by some Gram-positive bacteria, such as Bacillus anthracis
(17) and Clostridium difficile (18).
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It is unclear how MtbSecA2 carries out its unique function in
protein export. In some organisms with two SecAs, there is a SecY
paralog (SecY2), with which SecA2 likely interacts (19). In SecA2-
SecY2 systems, SecY2 and several accessory Sec proteins (Asp) are
thought to form an accessory protein translocation channel in the
cytoplasmic membrane (4). Mycobacteria, however, are in a
group of bacteria referred to as “SecA2-only” systems that lack a
second SecY ortholog (3). Mycobacteria, as well as several Gram-
positive species, includingListeriamonocytogenes (13),Corynebac-
terium glutamicum (20), and C. difficile (18), are in the “SecA2-
only” group. An important but unresolved question is whether
SecA2 works with the canonical SecYEG channel to export pro-
teins in these systems lacking a second SecY.
The mycobacterial proteins currently known to be exported by
SecA2 include examples with typical Sec signal peptides, as well as
proteins lacking signal peptides altogether (3). Superoxide dismu-
tase (SodA) in M. tuberculosis and PknG in M. tuberculosis and M.
marinum are examples of proteins lacking signal peptides that are
exported in a SecA2-dependent manner (7, 10, 21). Of the signal
peptide-containing proteins exported by the SecA2 systems of
Mycobacterium smegmatis (22), M. marinum (10), and M. tuber-
culosis (21), the most thoroughly studied proteins are the M. smeg-
matis 1704 (Ms1704) and Ms1712 proteins (22). Studies of
Ms1704 and Ms1712 demonstrate that they require their signal
peptide for export, but it is a feature of the mature portions of
these proteins that necessitates export via the SecA2-dependent
pathway (23). Interestingly, when fused to a signal peptide for the
twin-arginine translocation (Tat) pathway, the mature domain of
Ms1704 is exported by the Tat pathway. This result suggests that
the defining feature of SecA2 substrates may be a tendency to fold
prior to export (23). This is because proteins that get translocated
across the membrane by the Tat pathway must be folded in the
cytoplasm prior to export (24). In contrast, preproteins exported
by the canonical SecA must be unfolded (25), sometimes with the
help of export chaperones (26, 27), due to the narrow diameter of
the SecYEG central channel. Therefore, if SecA2 works with Se-
cYEG, the role of SecA2 may be to facilitate the export of proteins
that have a tendency to fold prior to export by either helping to
maintain such proteins in an unfolded state or assisting in the
recognition or export of such problematic substrates.
There is only 38% amino acid sequence identity between the
MtbSecA1 and MtbSecA2 proteins. Yet, SecA2, like SecA1, has a
DEAD box ATPase domain (28), and ATPase activity is required
for SecA2 function (29). Furthermore, SecA2 variants lacking
ATPase activity due to an amino acid substitution in the Walker
box are dominant negative, and a secA2 dominant-negative mu-
tant exhibits secA2 mutant phenotypes (a growth defect on rich
agar and azide sensitivity) that are more severe than those exhib-
ited by a secA2 null mutant (29). Extragenic suppressors of this
dominant-negative secA2 allele map to the secY promoter, and
increased SecY levels suppress the secA2 dominant-negative phe-
notype (30). These findings suggest that the SecA2 dominant-
negative protein is locked in a nonproductive interaction with the
essential SecYEG channel, which inhibits SecYEG function but
can be overcome by increased SecY production. This is consistent
with SecA2 working with SecYEG. In a recent study of the SecA2-
only system of L. monocytogenes, suppressors of a secA2 mutation
also mapped to secY (74). Furthermore, the behavior of a domi-
nant-negative SecA1 mutant in the C. difficile system is consistent
with the SecYEG translocase used by SecA1 also being used by
SecA2 (18). Thus, it seems likely that in these SecA2-only systems,
SecY is involved. However, a direct interaction between SecA2 and
SecYEG has not been demonstrated in any system.
Previously, the crystal structure of the canonical SecA1 was
solved in M. tuberculosis (31), as well as several other organisms,
including Escherichia coli (32), Bacillus subtilis (33), Thermotoga
maritima (34), and Thermus thermophilus (35). SecA structures
contain five canonical domains, organized roughly in the shape of
a barbell: a core helical scaffold domain (HSD), forming the “ax-
is”; 2 nucleotide-binding domains (NBD1 and NBD2), which to-
gether form a DEAD box, RecA-like, or superfamily II helicase
motor domain on one end of the barbell; and a helical-wing do-
main (HWD) and preprotein cross-linking domain (PPXD) on
the other end of the barbell. In addition, a helix-loop-helix do-
main called IRA1 (for “intramolecular regulator of ATPase”)
packs against the HSD, with helices aligned in parallel. The loop
connecting the helices of IRA1 is known as the two-helix finger
(2HF). The 2HF has been shown to insert into the SecYEG pore,
and it is proposed to promote forward movement of the prepro-
tein through the channel (34, 36), although the interaction be-
tween the 2HF and SecYEG could also serve an alternate role be-
sides pushing the translocating protein through the channel (37).
During preprotein translocation, SecA undergoes significant con-
formational changes, one of which involves the orientation of the
PPXD domain. According to one model (38), the PPXD likely
starts out oriented toward the HWD, forming a hydrophobic
“cleft” for binding the signal peptide of the preprotein (39, 40),
and then rotates toward NBD2 to form a “clamp” around the
translocating polypeptide chain, which has been proposed to be
initiated by docking with SecYEG (41).
In order to better understand the unique function of SecA2, we
solved the crystal structure of MtbSecA2, which is the first SecA2
structure to be determined in any organism. The structure reveals
that the HWD domain is completely absent in MtbSecA2. The
HWD could play a role in interacting with protein substrates, as it
forms part of a cleft with the PPXD that is implicated in peptide
binding (40). Although the residues that directly bind the signal
peptide (based on nuclear magnetic resonance [NMR] studies)
are contributed by the PPXD and IRA1 domains (40), the HWD
would likely be physically proximal to the untranslocated portion
of protein substrates. Furthermore, residues in the HWD of E. coli
SecA (along with the PPXD and HSD) have been shown to cross-
link with synthetic signal peptides in cysteine substitution exper-
iments (42). The lack of an HWD in SecA2 leads to a signal peptide
binding cleft that is more highly solvent exposed than in SecA1,
which we propose could account for recognition of specific
SecA2-dependent substrates and prevent export of the larger
number of SecA1-dependent preproteins. The structure also re-
veals conservation in MtbSecA2 of features critical to the interac-
tion between SecA and SecYEG proteins. Finally, by mapping
intragenic suppressor mutations onto the SecA2 structure, we
show that the mutated residues appear in surface-exposed re-
gions and map to three functional domains that are likely in-
volved in mediating interactions with other protein partners,
such as SecYEG.
MATERIALS AND METHODS
Protein expression and purification. The 778-residue open reading
frame (ORF) of MtbSecA2 was cloned into expression vector pNR14.
Several genomic databases list MtbSecA2 as having a total length of 808
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amino acids (aa) (e.g., NCBI accession no. NP_216337). However, the
start site in this annotation is likely to be incorrect, as the first 30 aa are not
required for function and represent an N-terminal extension that is not
observed in other SecA orthologs (28, 43). Therefore, we designate the
GTG codon corresponding to residue 31 in the NCBI annotation as the
true start codon, yielding a total ORF length of 778 aa. The expression
construct pNR14 produces a tag-less form of the protein (28). Selenome-
thionyl protein was produced by transforming the E. coli methionine
auxotroph B834(DE3) (Novagen) with the pNR14 expression vector. A
6-liter culture was grown under standard conditions to mid-log phase.
The cells were pelleted and used to inoculate 12 liters of M9 minimal
medium supplemented with 50 mg/liter of L-selenomethionine (SeMet),
50 mg/liter of standard L-amino acids (excluding methionine), 100 nM
vitamin B12, and trace elements (44). Expression was induced with 0.5
mM ITPG (isopropyl--D-thiogalactopyranoside) at 16°C for 12 h. Cells
were then harvested and resuspended in lysis buffer containing 50 mM
Tris (pH 8.0), 50 mM NaCl, 1 mM dithiothreitol (DTT), 10 mM MgCl2,
20 g/ml DNase, and 1 protease inhibitor cocktail V (EMD Biosci-
ences). The cells were disrupted in a BeadBeater (Biospec) using 0.1-mm-
diameter glass beads. Cellular debris was cleared from the lysate by spin-
ning at 27,200  g for 2 h. The supernatant was then filtered and loaded
onto a Blue Sepharose column (GE Healthcare) that had been equili-
brated in a mixture of 50 mM Tris (pH 8.0), 50 mM NaCl, and 1 mM DTT.
Protein collected from the flowthrough was further purified by anion-
exchange chromatography using a HiTrap Q high-performance (HP) col-
umn (GE Healthcare). The purified protein was dialyzed overnight
against buffer containing 50 mM Tris (pH 8.0), 50 mM NaCl, and 1 mM
DTT and was then concentrated to 10 mg/ml using a Centriprep centrif-
ugal concentrator (Milipore) and flash frozen until further use.
Crystallization. Purified protein was crystallized in 20% polyethylene
glycol 8000 (PEG 8000), 0.1 M Tris (pH 8.0), 0.2 M NaCl, 3% ethylene
glycol, and 8 mM 3-[(3-cholamidopropyl)dimethylammonio]-1-pro-
panesulfonate (CHAPS). Wells were set up using sitting-drop vapor dif-
fusion at 21°C, with drops consisting of 2 parts buffer and one part pro-
tein. Crystals grew to 100 m within 3 to 4 days. Perfluoropolyether
(Hampton Research) was used as a cryo-protectant. The protein crystal-
lized in space group P21 with the unit cell parameters a 39, b 165, c
67 Å, and 97°. The corresponding unit cell volume can accommodate
a single molecule in the asymmetric unit.
Crystal dehydration. A crystal dehydration method was developed
that significantly improved the mosaic spread and diffraction power of the
crystals (45). Both the well and drop solution were replaced with mother
liquor that had a 3 to 5% increase in precipitant concentration. Crystals
were left to dehydrate for a minimum of 48 h before making another
incremental increase in the precipitant. Successfully dehydrated crystals
had a reduced b unit cell parameter of up to 15 Å, with the largest differ-
ence resulting in a 10.5% decrease in the unit cell volume. The crystal that
produced the best diffraction data and led to structure solution had only a
3-Å difference in the b unit cell parameter.
Data collection, structure determination, and refinement. The
structure was solved by single-wavelength anomalous dispersion (SAD)
using a selenomethionine (SeMet) derivative (46). Anomalous diffraction
data were collected at beamline 23-ID of the GM/CA-CAT facilities of the
Advanced Photon Source, Argonne National Laboratory. Crystals were
partitioned using the 10-m minibeam (47). This prevented global-scale
radiation exposure and allowed for more data to be collected from a single
crystal. The data were processed and reduced using the HKL2000 soft-
ware package (48). The locations of 3 Se sites were found using SHELX
C/D and were used as a starting point for locating additional sites in
autoSHARP (49, 50). The resulting experimental phases extended to a
3.8-Å resolution and produced an electron density map in which approx-
imately 60% of the backbone could be placed in NBD1, NBD2, and parts
of the HSD. Model building was performed in Coot (51). The phases from
the partial model were then combined with the experimental phases using
SigmaA and used as a starting point for progressive runs of density mod-
ification in DM (52, 53). This facilitated the placement of the backbone in
the PPXD as well as in other parts of the model. Initially, sequence was
assigned by the positions of the Se atoms and from the density of large side
chains. Then a real-space cross-validation procedure called “ping-pong”
cross-validation was used to complete the structure (54). Briefly, the
model was split into two sets. Side chains that could be identified in the
first set of residues were used during phase combination and density mod-
ification. The resulting map was used to place side chains for the second
set of residues, and the process continued in alternation. Structure refine-
ment was carried out in autoBuster (55).
Suppressor screen and reconstruction. Spontaneous suppressors of
the secA2K129R strain were isolated by plating onto Mueller-Hinton agar at
37°C, as described previously (30). The secA2K129R strain has the chromo-
somal secA2 gene deleted and carries a copy of the secA2 gene encoding
SecA2K129R integrated at the chromosomal L5 att site. The secA2K129R gene
of the suppressors was PCR amplified and sequenced to identify intra-
genic suppressor mutations. To confirm that suppressor phenotypes were
due to sequenced mutations in secA2K129R, the intragenic suppressors
were recreated in a fresh strain background. PCR-amplified secA2K129R
gene products from the intragenic suppressors were subcloned into
pCR2.1 followed by cloning into pMV306. The resulting vectors were
electroporated into the secA2 mutant of M. smegmatis, and transfor-
mants were tested for sensitivity to sodium azide and SecA2 localization.
Azide sensitivity assay. Cultures were plated for sensitivity to sodium
azide as previously described (29). In brief, 200 l of saturated (optical
density at 600 nm [OD600] of 2.0) M. smegmatis culture was mixed with
3.5 ml of molten 7H9 top agar and then poured onto a 7H10 bottom agar
plate lacking Tween. Sterile 6-mm-diameter filter discs were placed onto
the surface of the cooled top agar. Ten microliters of 0.15 M sodium azide
was then added to the disc. The plates were incubated for 2 days at 37°C,
and the resulting zones of growth inhibition were measured. Each strain
was tested in triplicate.
Subcellular fractionation and immunoblotting. To determine the
subcellular localization of SecA2 in M. smegmatis, we fractionated bacte-
rial whole-cell lysates as described previously (22, 29). Whole-cell lysates
were generated by five passages through a French pressure cell. The lysates
were separated into cell envelope (100,000  g pellet) and soluble
(100,000  g supernatant) fractions. Protein derived from the same
amount of starting cells for each fraction was analyzed by SDS-PAGE and
immunoblots using an anti-SecA2 antibody at a 1:20,000 dilution (56).
For quantification, secondary antibody conjugated to alkaline phospha-
tase was used and detected using the ECF reagent (GE Healthcare). Fluo-
rescence was quantified using a phosphorimager and ImageQuant 5.2
(Molecular Dynamics).
Protein structure accession number. The structural coordinates of
the MtbSecA2 model used in this study have been deposited in the Protein
Data Bank under identification no. 4UAQ.
RESULTS
Crystal structure ofMtbSecA2. MtbSecA2 (Rv1821) was crystal-
lized in space group P21, and the structure was solved by single-
wavelength anomalous dispersion (SAD) (57) to a resolution of
2.8 Å. The asymmetric unit of the crystal contains a single mono-
mer, and there is no indication of a higher-order oligomer in the
crystal lattice. A total of 705 out of 778 residues of the apoprotein
were visible in the electron density and could be built. The crys-
tallographic statistics are shown in Table 1.
Broad structural similarity betweenMtbSecA1 andMtbSecA2.
The tertiary structure of SecA2 is very similar overall to those of
MtbSecA1 and other orthologs in the SecA family (Fig. 1). SecA2
has a long 65-Å (45-amino-acid) helix scaffold domain (HSD),
which interconnects four other domains, including two nucle-
otide-binding domains (NBD1 and NBD2), the IRA1 domain,
and the PPXD domain. NBD1 and NBD2 pack together to form a
Swanson et al.
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DEAD box motor domain with an ATP-binding site between
them. Catalytically important residues, such as K115 and R545 are
conserved (see Fig. S1 in the supplemental material), consistent
with demonstrated ATPase activity of SecA2 (28). As in other SecA
structures, the IRA1 domain consists of a pair of alpha-helices
packed in parallel to the HSD (forming a 3-helix bundle) and
connected by a 9-aa loop (known as the 2-helix finger [2HF]).
SecA2 lacks the70-aa C-terminal domain (CTD) that is present
in SecA1 orthologs. However, the short linker to this domain,
called the C-terminal linker (CTL [residues 734 to 778]), is re-
tained in the SecA2 sequence. The CTL is largely disordered in the
crystal structure. However, as observed in previous SecA struc-
tures (33), part of the CTL of SecA2 (residues 749 to 759, shown in
yellow in Fig. 1) forms a third -strand along the outside the
preprotein binding site. Note that this region is preceded by a
disordered loop (residues 734 to 748), which appears as a discon-
tinuity between IRA1 and CTL in the figure, and followed by only
19 residues to the C terminus, which are also disordered. During
model building, sequence assignment in this strand was aided by
the location of SeMet757 and the density of bulky side chains,
which helped to rule out the possibility of a bound preprotein
substrate.
Differences between the structures of MtbSecA1 and
MtbSecA2. Despite the overall similarity between the structures
of SecA1 and SecA2, there are several notable differences. One
structural difference between SecA1 and SecA2 is found in the
nucleotide-binding region. SecA2 lacks the VAR domain (58),
which in other SecA orthologs consists of a pair of helices that
reach out from NBD2 and cover over the ATP-binding site (Fig.
2). Consequently, the ATP binding site is more solvent exposed in
SecA2. The VAR domain is present in some SecA orthologs, in-
cluding MtbSecA1 (31) and E. coli SecA (32), but it is absent in
others, such as B. subtilis SecA (33) and T. maritima SecA (Tm-
SecA) (39). The functional significance of the absence of the VAR
domain in SecA2 is unknown.
A second structural difference involves the orientation of the
PPXD domain. As in other SecA structures, the PPXD domain
consists of an 	-fold that is attached to the NBD1 motor do-
main by a pair of anti-parallel -strands that cross over the HSD.
The PPXD of M. tuberculosis SecA2 occupies a distinct orientation
TABLE 1 Data collection and refinement statistics for SAD (SeMet)
structure of SecA2
Parameter Value(s) for SecA2a
Data collection
Space group P21
Cell dimensions
a, b, c (Å) 39.60, 162.09, 67.31
, , 
 (°) 90.00, 95.87, 90.00
Wavelength (Å) 0.97949
Resolution (Å) 35.64–2.8 (2.85–2.8)
Rsym or Rmerge (%) 0.096 (0.171)
Avg I/Ic 24.3 (1.4)
Completeness (%) 0.72 (0.168)
Redundancy 4.1 (1.9)
Refinement
Resolution (Å) 2.8
No. of reflections 16,255
Rwork/Rfree 0.291 (0.212)
No. of atoms
Protein 4,894
Water 67
B-factors
Protein 85.2
Water 58.3
RMSDb
Bond length (Å) 0.01
Bond angle (°) 1.26
a Values in parentheses are for the highest-resolution shell.
b RMSD, root mean square deviation.
c I, intensity of a reflection.
FIG 1 Domain architecture of MtbSecA2. Orange, NBD1; green, NBD2; cyan,
PPXD; magenta, IRA1; black, HSD; yellow, C-terminal linker (CTL).
FIG 2 Comparison of MtbSecA2 with MtbSecA1. Relative to SecA1 (gray
backbone) (PDB code 1NL3), SecA2 (tan backbone) is smaller, lacking the
HWD (red) and the VAR domain (yellow). Also, the PPXD domain has un-
dergone rotation (SecA1 [blue]¡ SecA2 [cyan]).
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compared to previous SecA structures, as illustrated in Fig. 3. The
PPXD in previous SecA structures had been observed in several
different orientations, ranging from contact with the HWD (to
form a “signal peptide binding-cleft closed” conformation, as ob-
served in 1nl3) to contact with NBD2 (to form a “preprotein
clamp closed” conformation, as observed in PDB code 3DIN) (38,
59) produced by a rigid-body rotation relative to the rest of the
protein (38, 39). The PPXD in SecA2 occupies an intermediate
position between these two extremes.
The most striking structural difference in SecA2 is that the
HWD is missing (Fig. 2) due to deletion of 70 aa that form a helical
domain at the end of the HSD, as anticipated from the sequence
alignment (see Fig. S2 in the supplemental material). In SecA2, the
remaining 23 residues connect the HSD directly to IRA1, bypass-
ing the helical wing domain. In other SecA structures, including
MtbSecA1, the body of the HWD forms a deep hydrophobic cleft
with PPXD, which can open or close against it (39), with the signal
peptide binding site at the base (formed by residues from PPXD
and IRA1) (39, 40). The absence of the HWD in SecA2 makes the
cleft significantly more open and solvent exposed (illustrated in
Fig. S3 in the supplemental material), which could help SecA2
recognize its unique substrates that are distinguished by features
of their mature domains—possibly a tendency to fold prior to
export (23).
The functionally important two-helix finger (2HF), which is a
9-residue loop connecting two helices in the IRA1 domain that
inserts into the SecYEG pore, is conserved in the MtbSecA2 struc-
ture (residues 695 to 703) (Table 2). However, the 2HF loop in
MtbSecA2 adopts a different three-dimensional conformation
compared to previous structures. In the MtbSecA2 structure, the
2HF is observed to close down approximately 10 Å onto the HSD,
like a jaw hinge (Fig. 4), due to differences in how the ends of the
helices unwind (even though the 2HF amino acid sequence itself is
highly conserved, as shown in Table 2). This orientation contrasts
with the conformation observed in most other SecA structures, in
which the loop is more flipped out into solvent (Fig. 4); however,
the conformations of the 2HF loop are also quite variable among
SecA crystal structures (see Fig. S4 in the supplemental material).
Fluorescence studies also suggest that the 2HF loop is flexible and
can adopt different conformations in solution (37).
Similarities between SecYEG binding regions ofM. tubercu-
losis SecA1 and SecA2. The conservation of the overall structure
of SecA2 is consistent with a model in which SecA2 works with
SecYEG to translocate SecA2-dependent proteins across the
membrane. Furthermore, the key regions of SecA2 that would
interact with the SecYEG pore are conserved, including the 2HF.
The helix-terminating proline in the 2HF is present in SecA2
(Pro703), as it is in all SecA homologs (Table 2). Tyr794 in E. coli
FIG 3 Comparison of different orientations of the PPXD domain. Shown are
MtbSecA2 (cyan), MtbSecA1 (PDB code 1NL3) (dark blue), B. subtilis SecA
(PDB code 1TF2) (yellow), and the TmSecA-SecYEG complex (PDB code
3DIN) (red). All four PPXD domains are superposed onto the body of
MtbSecA2 (orange). At one extreme, in the MtbSecA1 structure (right, dark
blue), the PPXD is packed against the HWD (missing in SecA2), representing
the signal peptide-recognition site closed conformation. At the other extreme
(left, red), the PPXD from the T. maritima complex with SecYEG represents
the “preprotein clamp closed” configuration, where contact is made with
NBD2 (orange, lower left). The MtbSecA2 PPXD occupies a unique interme-
diate position (cyan).
TABLE 2 Conservation of the 2HF among SecA homologs
Species Protein Sequencea
E. coli SecA1 LRGYAQKDP
T. maritima SecA1 LRSYGQKDP
M. tuberculosis SecA1 LRAMAQRDP
M. smegmatis SecA1 LRAMAQRDP
M. tuberculosis SecA2 LRALGRQNP
M. avium SecA2 LRALGRQNP
M. smegmatis SecA2 LRALGRQNP
S. aureus SecA2 LRSYAQQNP
L. monocytogenes SecA2 LRAYGQIDP
S. gordonii SecA2 LRGYAQNNP
C. difficile SecA2 LKSYAQKDP
C. glutamicum SecA2 LRAIARETP
a Key residues are underlined.
FIG 4 Conformation of the two-helix finger (2HF). The HSD of MtbSecA2
(cyan) is shown superposed on the apo structure of MtbSecA1 (purple). The
loops connecting the two helices are shown in orange (SecA1) and green
(SecA2).
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SecA is another critical residue in the 2HF (36). Although it is
substituted for by Leu698 in MtbSecA2, this tyrosine is substituted
by large hydrophobic residues in 20% of SecA homologs (methi-
onine in MtbSecA1). Furthermore, structural data from the
TmSecA-SecYEG complex supports that hydrophobic substitu-
tions, such as leucine, can be accommodated at this position, as
the side chain sits in a hydrophobic pocket in SecY (34).
Structural superposition of MtbSecA2 onto TmSecA in the
TmSecA-SecYEG complex (PDB code 3DIN [34]) (Fig. 5; see Fig.
S5 in the supplemental material) further indicates that SecA2 pre-
serves many of the structural features of SecA implicated in bind-
ing to SecYEG. This includes amino acids in the MtbSecA2 2HF
and immediately adjacent regions of IRA1 that contact SecY in the
TmSecA-SecYEG complex (aa 687 to 715 in SecA2) (Table 3 and
Fig. 5). There are also regions of NBD2 and the HSD that are
structurally conserved in the SecA2 structure and positioned for
contact with SecY (Table 3 and Fig. 5). These residues in NBD2,
IRA1, and the HSD are clustered at the interface with SecY. In
addition, although the PPXD of SecA2 is rotated away and does
not appear to make direct contact with SecY in the superposition,
if it were rotated into an orientation similar to that observed in
TmSecA in the complex, it would place additional SecA2 residues
(listed in Table 3) in contact with SecY, as shown in Fig. 5. It is
notable that MtbSecA2 D607 (in the HSD) corresponds to one of
the residues in E. coli SecA (position 640) that can be cross-linked
with SecY using photoactivatable unnatural amino acids (60).
Mapping of suppressor mutations on the SecA2 structure.
Prior studies indicate that a SecA2 dominant-negative protein
with an amino acid substitution in the ATP binding Walker box,
making it unable to bind ATP, is locked in a nonfunctional com-
plex, likely with SecYEG, at the membrane (29). In order to iden-
tify important residues in SecA2, we identified intragenic suppres-
sor mutations that could overcome the secA2 dominant-negative
phenotypes (30) with the rationale being that such mutations
might map to sites of protein interactions in SecA2 complexes. For
convenience, these experiments were performed with the M.
smegmatis ortholog of SecA2, which has 83% amino acid identity
to MtbSecA2 and is able to substitute for the MtbSecA2 in cross-
species complementation experiments (29). An M. smegmatis
strain expressing the dominant-negative MsSecA2K129R, which
has an amino acid substitution in the Walker box (equivalent to
K115 in MtbSecA2) was used. All suppressors identified reversed
the severe dominant-negative phenotypes caused by SecA2K129R,
as assessed by azide sensitivity assays (5) and colony size on rich
agar (30) (Fig. 6 and data not shown), but they still exhibited a
phenotype similar to that of a secA2 null mutant.
Eight independent suppressors with mutations in the coding
sequence of secA2K129 were identified by sequencing, mapping to
four different domains: NBD1, NBD2, PPXD, and IRA1 (Table 4).
All eight suppressor mutants produced full-length SecA2 protein
at normal levels, as confirmed by Western blot analysis. Each mu-
tation was validated to be responsible for the suppression by re-
testing the phenotype of individual mutations when introduced
into a fresh secA2K129R mutant background (Fig. 6).
When mapped to the SecA2 structure, all of the suppressor
mutations were located on the surface of the protein (Fig. 7). For
simplicity, below we will refer to the suppressors using amino acid
numbering that corresponds to MtbSecA2 (Table 4). There were
three categories of suppressors. The first set of suppressor muta-
tions affected the same surface loop of NBD1. There were two
suppressors derived from independent cultures with identical
mutations in NBD1 and a third suppressor with a different muta-
tional alteration that mapped to the same site in NBD1. These
NBD1 suppressors involve a 4-residue loop, 168STPD172, in M.
tuberculosis connecting a -strand and an -helix; this loop was
deleted in one mutant and duplicated in another. It is currently
unknown what role these residues play, but it is striking that three
out of eight suppressor mutations involved this surface-localized
loop of the nucleotide binding domain, suggesting it is a function-
ally important point of contact for SecA2.
The second group of suppressors (three in total) clustered in
the SecA “polypeptide clamp” region made up of PPXD and
NBD2 domains. Two suppressor mutations mapped to the SecA2
PPXD domain: a nonsynonymous substitution, D316H, and an
insertion of a second glutamate at E354. These amino acids are in
separate loops in the PPXD domain, but they are proximal in the
three-dimensional structure, approximately 7 Å apart (Fig. 7a).
The PPXD is positioned far from the NBD2 domain in the SecA2
structure. (The distance between the closest residues of the two
domains is 23 Å, representing a “clamp open” state.) However, in
the TmSecA-SecYEG complex, the corresponding PPXD loops to
which these suppressor mutations map come in contact with
NBD2. Moreover, the TmSecA residue corresponding to the
D316H suppressor in the MtbSecA2 PPXD is in direct contact
FIG 5 Interface residues (red) of MtbSecA2 (tan) that would contact SecYEG
(cyan), based on superposition with TmSecA (PDB code 3DIN). Note that the
red residues highlighted in the PPXD correspond to residues of TmSecA that
contact SecYEG as its PPXD is rotated into contact with SecYEG.
TABLE 3 Residues of MtbSecA2 predicted to be in contact with SecY
based on structural superposition with TmSecA in complex with
SecYEG (PDB code 3DIN)
Domain MtbSecA2 residues predicted to contact SecY
NBD1 None
NBD2 E392, R395, Q396
HSD V600, R604, D607, A610, R614
IRA1 Most residues spanning 687–715 (including residues of the
2HF and surrounding IRA1 helices)
PPXD N270, H272, T274, E275, D289
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with NBD2 in the TmSecA-SecYEG complex (34) (Fig. 7b). It
should be noted that this TmSecA complex with SecYEG repre-
sents an extreme conformation (induced by ADP and BeFx in the
crystallization buffer) in which the preprotein channel is entirely
collapsed (i.e., a loop of the PPXD actually inserts into the prepro-
tein binding channel). In a structure of SecA bound to a prepro-
tein substrate (PDB code 3JV2 [61]), the PPXD does not rotate
quite as far toward NBD2 as in the SecA-SecYEG complex, but the
residues corresponding to the suppressor mutations are still on
the surface of the PPXD in a region that would be in position to
interact with SecYEG or the lipid bilayer (similar to the red resi-
dues highlighted in Fig. 5). Thus, these suppressor mutations
could disrupt intramolecular interactions when the PPXD rotates
to form the “clamp” around the translocating polypeptide (41) or
could lock it in the extreme closed state such that the preprotein
channel is collapsed altogether. Strikingly, the NBD2 suppressor
T449I in M. tuberculosis also maps to the SecA “preprotein clamp”
region and is proximal (within 10 Å) to the two PPXD suppressor
mutations when the clamp is closed (based on the analogous res-
idues in the TmSecA-SecYEG docked structure [34]) (Fig. 7).
Thus, these three suppressors in NBD2 and PPXD could conceiv-
ably cause a defect in clamp closure during translocation. In light
of past studies suggesting that interactions between SecA2K129R
and SecYEG are responsible for the dominant-negative phenotype
(30), these results suggest that a defect in clamp closure may dis-
lodge or prevent SecA2 interactions with SecYEG by disrupting
interactions with the polypeptide being translocated through the
channel.
The final group of intragenic suppressors identified have dele-
tions in IRA1. One suppressor has a deletion of residues 714 to 721
in M. tuberculosis, and another suppressor has a very similar, yet
distinct, deletion of residues 712 to 719 in M. tuberculosis. These
deletions are in the middle of one of the -helices, just down-
stream from the 2HF that forms part of the interface with SecYEG
(Fig. 5 and 7 and Table 3), and similar mutations in IRA1 have
previously been shown to disrupt binding to SecYEG (62). Fur-
thermore, one of the deleted residues in both of the IRA1 suppres-
sors is Phe715, which is a conserved residue predicted to contact
SecY (colored red in Fig. 5) that is equivalent to the highly con-
served Phe798 (in TmSecA). In the TmSecA-SecYEG structure,
Phe798 (in TmSecA) forms an aromatic stacking interaction with
Tyr418 in the C-terminal tail of TmSecY (34). This interaction
appears to be crucial to docking as the equivalent tyrosine residue
in E. coli SecY (Tyr429) is the location of a cold-sensitive mutation
that prevented insertion of SecA into the membrane channel (63).
These interacting residues are highly conserved in all Sec systems,
including MtbSecA2 (Phe715) and MtbSecY (Tyr436). The fact
that this group of intragenic secA2 suppressor mutants harbors
deletions in a structurally conserved and critical SecY-interacting
region of IRA1 (Fig. 5 and Table 3) is consistent with their mode of
suppression being avoidance of complex formation between
SecA2K129R and SecYEG.
Intragenic suppressors alter membrane localization of the
dominant-negative SecA2. In the wild type, MsSecA2 is predom-
inantly found in the soluble cytoplasm-containing fraction. In
contrast, the localization of SecA2K129R is almost exclusively in the
membrane-containing cell envelope pellet (29) (Fig. 8). This is
consistent with a model for SecA2K129R being locked in a protein
complex with SecYEG at the membrane. Since we predicted that
some of the intragenic suppressors alleviate SecYEG interactions,
we determined the membrane localization of SecA2K129R in the
intragenic suppressor mutant background. Strains were lysed and
then fractionated into cell envelope (pellet) and soluble (cytoplas-
mic) fractions. Western blot analysis with anti-SecA2 antibodies
on fractions was then carried out to localize the protein. In each of
the representative intragenic suppressors analyzed, the distribu-
tion of SecA2K129R shifted from the envelope, as seen in the start-
ing secA2K129R strain, to the soluble cytoplasmic fraction (Fig. 8).
Suppressor mutations in the “clamp” (PPXD and NBD2) and
IRA1 domains had the most dramatic effects, restoring partition-
FIG 6 Intragenic suppressors suppress the azide sensitivity phenotype of secA2K129R. Lawns of the indicated strains were plated and tested for sensitivity to 10l
of 0.15 M sodium azide (applied to a paper disk in the center of the plate) for 2 days at 37°C. Average inhibition was calculated by measuring the diameter of the
zone of azide inhibition, and values are the means of three biological replicates. The secA2 mutant M. smegmatis strain was transformed with plasmids
containing either secA2, secA2K129R, or a reconstructed intragenic suppressor with the secA2K129R mutation in combination with an intragenic suppressor
mutation located in one of the following domains: NBD1, NBD2, PPXD, or IRA1.
TABLE 4 Suppressor mutations observed in M. smegmatis SecA2K129R
Isolate(s)a Effect on residue(s) in MsSecA2 Domain
Corresponding
residue(s) in
MtbSecA2
6S, 9S Deletion of residues 182–185 NBD1 168–171 (STPD)
23S* Duplication of residues 182–185 NBD1 168–171
2S Asp326¡His PPXD D316
25S* Glu insertion at residue 364 PPXD E354
34S* Thr459¡Ile NBD2 T449
21B* Deletion of residues 734–741 IRA1 714–721
38S Deletion of residues 732–739 IRA1 712–719
a An asterisk indicates the suppressor was subcloned and retested in M. smegmatis.
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ing of SecA2 between the cell envelope and cytoplasm to almost
wild-type levels. These data support a model in which the intra-
genic suppressor mutations alleviate the dominant-negative phe-
notype by disrupting protein-protein interactions involving the
SecYEG membrane complex and/or the translocating polypep-
tide.
DISCUSSION
Over 30 years ago, SecA was identified as a critical component of
the protein export system of bacteria (64). Since that time, there
have been extensive genetic, molecular, biochemical, biophysical,
and structural studies to understand SecA function. Of the two
SecAs in M. tuberculosis, SecA1 is the counterpart of the well-
studied canonical SecA, while SecA2 has a distinct function from
SecA1 and a nonoverlapping substrate specificity profile. The
structure of MtbSecA2 we report is the first structure of any SecA2
protein. The broad structural similarity observed between the two
solved MtbSecA structures indicates that, even after decades of
mechanistic studies, gaps in our understanding of SecA proteins
remain.
The smaller size of SecA2 versus SecA1 and canonical SecA
proteins appears to come from the absence of the HWD, the VAR
domain, and a C-terminal domain (CTD [although it still retains
the CTL linker]) reducing the overall size of the protein product
from 949 aa to 778 aa (see Fig. S2 in the supplemental material).
The lack of an HWD is the most striking structural difference in
SecA2. Without the HWD, the signal peptide recognition site of
SecA2 is more solvent exposed and thus more accessible to protein
substrates. This structural difference may help explain the ability
of SecA2 to export substrates with distinctive features of their
mature domain, possibly a propensity to fold prior to export (23).
The “open” nature of the cleft created by the absence of a HWD
could provide a broad surface against which folded proteins could
possibly dock and unfold for translocation through the SecYEG
transmembrane pore. Several pieces of experimental evidence
support the possibility that the HWD could interact with prepro-
teins. While a nuclear magnetic resonance (NMR) structure of
SecA bound to a signal peptide did not identify any residues of the
HWD that directly interact with the signal peptide (40), several
residues of the HWD were found to form cysteine-based cross-
links with a synthetic signal peptide (42), which may result from
transient states (i.e., alternative conformations of the HWD) sam-
pled dynamically in solution. In fact, the HWD is observed to
rotate by up to 15° between different crystal structures, depending
on the oligomeric state (39). This suggests the HWD itself is mo-
bile in solution, which is supported by fluorescence-based (fluo-
FIG 7 (a) Suppressor mutations from MsSecA2K129R mapped onto MtbSecA2. Mutations are shown as yellow spheres. (b) Suppressor mutations mapped onto
the TmSecA complex with SecYEG (PDB code 3DIN). In the complex with SecYEG, SecA is in the “preprotein clamp closed” conformation, in which PPXD
(cyan) is swung down (arrow) to make contact with NBD2 (green). In this conformation, the residues affected by the suppressor mutations in the PPXD and
NBD2 domains can be seen to come into contact (circled).
FIG 8 Subcellular localization of SecA2 is altered in intragenic suppressors of
secA2K129R. Whole-cell lysates of the indicated strains were fractionated into a
cytoplasm-containing soluble fraction and membrane-containing cell enve-
lope fraction. Representative intragenic suppressors (PPXD, NBD2, IRA1, and
NBD1) are indicated. Protein derived from an equal number of cells was ana-
lyzed by SDS-PAGE, and quantitative immunoblot analysis with anti-SecA2
antibodies was performed. The percentage of localization in a given fraction is
plotted. Error bars represent the means from three independent replicates.
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rescence resonance energy transfer [FRET]) studies (65). Further-
more, the mobility of the HWD appears to be influenced by the
presence of a preprotein (66). Thus, the absence of the HWD in
SecA2 could potentially affect substrate recognition. The 70-resi-
due deletion of the HWD observed in MtbSecA2 is a general fea-
ture among actinomycetes (includingMycobacterium andCoryne-
bacterium species) (see Fig. S2 in the supplemental material). It
should be noted that other Gram-positive SecA2 proteins also
appear to have a truncated version of this domain (deletions of 13
to 18 residues for Streptococcus gordonii and L. monocytogenes,
respectively). Until structures of these other SecA2 orthologs are
solved, the potential consequences of these HWD truncations re-
main unknown. It is possible that a reduced HWD could open up
the signal peptide binding cleft and/or increase the site of interac-
tion with preproteins, as we propose for MtbSecA2. To achieve a
complete picture of SecA2 function going forward, the conse-
quences of a truncated or deleted HWD will need to be explored in
both mycobacterial and Gram-positive SecA2 proteins.
The significance of the absence of the VAR domain in the
SecA2 NBD region is less clear. The lack of the VAR domain leaves
the nucleotide-binding site relatively solvent exposed. While other
SecA2 orthologs also lack the VAR domain (see Fig. S2 in the
supplemental material), one-third of bacterial SecA (1) proteins
lack this domain as well (58). In E. coli SecA, the VAR domain has
been shown to regulate ATPase activity and ADP release, as secA
var mutants display higher ATPase activity and faster ADP re-
lease rates (58). However, MtbSecA2 (28) was recently reported to
release ADP more slowly (not more quickly) than the VAR-con-
taining MtbSecA1 (67).
Mycobacterial SecA2 proteins, as well as SecA2s in many other
organisms, lack the C-terminal domain (CTD) (see Fig. S2 in the
supplemental material). The CTD in SecA1 proteins consists of a
tail of 70 aa that is disordered in all previous crystal structures
(1). In most bacteria, the CTD of SecA contains a Zn2	 finger
domain that binds to the protein export chaperone SecB (68).
Mycobacteria are an exception, in that the CTD of SecA1 does not
contain the conserved cysteines of a Zn2	 finger motif. However,
this may not be too surprising because, like Gram-positive bacte-
ria (69), no SecB ortholog with a function in protein export has so
far been identified in mycobacteria. Thus, because of the lack of
Zn2	 finger motif in the CTD of SecA1 and lack of a SecB or-
tholog, the absence of a CTD in MtbSecA2 seems unlikely to be a
significant contributing factor to the unique function of SecA2.
In comparison to all prior SecA structures, the SecA2 structure
also revealed new orientations of the PPXD and the 2HF loop.
However, these differences probably reflect the conformational
plasticity of these two structural elements. Given the mobility of
the PPXD domain already established for canonical SecA proteins,
it seems likely that the PPXD orientation observed in SecA2 rep-
resents a previously unobserved structural intermediate in the
transition of the preprotein binding clamp from the open to
closed position (38). The unique orientation of the 2HF loop ob-
served in SecA2, which occurs at a key point of interaction with the
translocation channel and varies considerably among SecA struc-
tures, is probably a consequence of the flexibility of this loop in
solution.
Given that there is no corresponding SecY2 partner in the M.
tuberculosis genome, an important mechanistic question to be an-
swered is whether SecA2 works with the canonical SecYEG chan-
nel to export proteins. In prior studies, we described a dominant-
negative secA2 mutation that exhibits more severe phenotypes
than asecA2 deletion mutant (29). Such phenotypes often result
from a dominant-negative protein being locked in a nonproduc-
tive complex with its normal binding partners. Furthermore, we
showed extragenic suppressors that overexpress SecY suppress the
secA2K129R dominant-negative phenotype, which argues for an in-
teraction between SecA2K129R and SecY (30). Here, we identified
intragenic suppressors of secA2K129R, and all of them mapped to
the surface of the SecA2 structure. One group of suppressors
mapped to the IRA1 domain of SecA2 in regions where similar
mutations disrupt E. coli SecA binding to SecYEG (62). These
IRA1 suppressors also restored cytoplasmic localization of
SecA2K129R. These results can be explained by the IRA1 suppressor
mutations preventing SecA2K129R interactions at the membrane
SecYEG channel, and they support the model for SecA2 working
with SecY to promote export of its specific substrates. The sup-
pressors that mapped to the “polypeptide clamp” region of SecA
could similarly suppress the dominant-negative phenotype. How-
ever, in this case, the suppression would result from the inability of
SecA2 to trap the translocating polypeptide in the center of the
SecYEG channel, causing SecA2 to fail to engage SecYEG (without
the substrate) or causing the ternary system (SecYEG-SecA2-pre-
protein) to dissociate.
The SecA structure reported here is of a monomer. In other
studies, SecA proteins have been crystallized as monomers (54) or
dimers (39), and the issue of the oligomeric state of SecA during
protein translocation has remained controversial (37, 70–72). A
recent study demonstrated the ability of recombinant MtbSecA1
and MtbSecA2 to physically interact in vitro (73). If SecA1-SecA2
heterodimers form, it is possible that interactions between SecA1
and SecY avoid the need of SecA2 to directly interact with SecY.
However, it is currently unclear if SecA1-SecA2 dimers exist
and/or are functional in mycobacteria. Furthermore, the domi-
nant-negative SecA2 phenotypes and the intragenic suppressors
reported here, combined with structural conservation of SecA-
SecY contact sites in SecA2, argue for the ability of SecA2 and SecY
to interact. Ultimately, to clarify the mechanistic details of SecA2-
dependent protein export, it will be necessary to study the path-
way with an in vitro reconstitution system, as was used to dissect
the mechanistic details of the E. coli Sec pathway.
Since the SecYEG channel requires that proteins be un-
folded for translocation (25), the possibility of SecA2 working
with the SecYEG channel is intriguing, in light of experiments
suggesting that SecA2 substrates are distinguished by a ten-
dency to fold in the cytoplasm (23). The role of SecA2 could be
to promote recognition of proteins that would normally be
overlooked by the canonical SecA1-SecYEG translocase or to
help maintain proteins in an unfolded state prior to or during
export. The regions of structural difference and suppressor
mutations identified in this study represent exciting new direc-
tions for exploring the functional differences between SecA2
and SecA1 proteins.
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